30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Hoffman

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -23% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chairman of the Board TuHURA Biosciences Inc June 2, 2018 -
Chief Financial Officer, Senior Vice President - Finance Heron Therapeutics Inc April 1, 2017 -
Independent Chairman of the Board TuHURA Biosciences Inc June 2, 2018 -
Independent Director CombiMatrix Corp July 15, 2013 -
Independent Director Kura Oncology Inc March 1, 2015 -
Independent Director Aravive Inc Oct. 12, 2018 - April 8, 2020
Independent Director TuHURA Biosciences Inc None -
Independent Director MabVax Therapeutics Holdings Inc Sept. 8, 2014 - Dec. 31, 2017
Chief Financial Officer, Executive Vice President, Principal Accounting Officer Innovus Pharmaceuticals Inc Sept. 6, 2016 - April 21, 2017
Chief Financial Officer, Senior Vice President - Finance Arena Pharmaceuticals Inc June 15, 2012 - July 10, 2015
Chief Financial Officer, Vice President - Finance Arena Pharmaceuticals Inc Aug. 29, 2011 - June 15, 2012

Robert Hoffman's trades of TuHURA Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-02-17 2022-02-15 B Purchase
39,993 -25.2%
453.50
US$1,239,369
39,993 -25.2% 453.50 US$1,239,369